Educational guide
Adrenomedullin vs Intermedin (Adrenomedullin-2) — Peptide Comparison
At a Glance Quickcomparison Dose Range Adrenomedullin As prescribed–As prescribed mg Intermedin (Adrenomedullin-2) Frequency Once daily Administration Intravenous infusion As directed by healthcare provider Cycle Length Ongoing/indefinite Onset Speed Moderate
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
At a Glance
Quickcomparison
Dose Range
Adrenomedullin
As prescribed–As prescribed mg
Intermedin (Adrenomedullin-2)
Frequency
Once daily
Administration
Intravenous infusion
As directed by healthcare provider
Cycle Length
Ongoing/indefinite
Onset Speed
Moderate (1-2 weeks)
Evidence Level
Moderate human trials (Phase 1-2)
Limited human trials
Efficacy
Benefitratings
Cardiovascular Support
Tissue Protection
Immune Function
Cardiovascular Health & Protection
Stress & Anxiety Management
Anti-Inflammatory & Antioxidant Support
Technical Data
Compoundspecifications
Molecular Formula
C264H406N80O77S3
Molecular Weight
6029 Da (Daltons)
Half-Life
Approximately 20-30 minutes in plasma (rapid metabolism)
Bioavailability
Parenteral administration only; peptide undergoes proteolytic cleavage in circulation
CAS Number
148498-78-6
C15H25NO5 (precursor compound)
299.36 g/mol (precursor)
Approximately 2-6 hours (varies by route of administration)
Varies by route of administration
Protocols
Dosingtiers
starting
5 ng/kg/min
Continuous infusion, 8 hours per day
14 days (trial protocol)
Adrenomedullin is given as a slow drip into a vein in clinical trials, not by self-injection. This low dose was the bottom step tested for steroid-resistant ulcerative colitis. [4]
standard
10 ng/kg/min
Middle dose tested in the ulcerative colitis trial. [4]
advanced
15 ng/kg/min
This higher dose was the only one that significantly improved disease scores in the trial. The same 15 ng/kg/min rate was also tested safely in healthy volunteers. [4][5]
Applications
Bestsuited for
Cardiovascular health optimization
Adrenomedullin is particularly well-suited for individuals focused on cardiovascular health optimization. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Maintaining healthy blood pressure
Adrenomedullin is particularly well-suited for individuals focused on maintaining healthy blood pressure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Recovery from illness or sepsis
Adrenomedullin is particularly well-suited for individuals focused on recovery from illness or sepsis. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Tissue protection and oxygen delivery
Adrenomedullin is particularly well-suited for individuals focused on tissue protection and oxygen delivery. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting cardiovascular health and heart function
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on supporting cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Managing inflammation and oxidative stress
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on managing inflammation and oxidative stress. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving overall vascular health and circulation
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on improving overall vascular health and circulation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety Profile
Sideeffects
Common
Mild discomfort at treatment site
Excessive blood pressure lowering (hypotension)
Headaches (from pressure changes)
Flushing and mild facial redness
Dizziness or lightheadedness
Mild electrolyte shifts
Localized injection site reactions
Increased urination (natriuretic effect)
Serious
Severe allergic reaction
Mild headache
Injection site reactions (redness, itching, swelling)
Nausea or mild gastrointestinal discomfort
Fatigue or mild energy changes
Transient hypotension (temporary low blood pressure)
Mild palpitations (in some individuals)
Research Status
Safety& evidence
FDA Status
Research compound
Safety Overview
Adrenomedullin safety in humans is poorly characterized, with clinical data limited to observational studies and small uncontrolled trials in cardiovascular patients. Animal studies demonstrate potent vasodilatory effects that could lower blood pressure dangerously, particularly in patients on antihypertensive medications. No human pharmacokinetic studies have established safe doses, and potential for hypotension, electrolyte disturbances, and off-target vasodilation effects exists. The peptide crosses the blood-brain barrier and affects central nervous system function in animal models, raising concerns about neurological effects at higher doses.
Contraindications
xSevere hypotension or shock states
xConcurrent use with certain vasopressor medications
xPregnancy and breastfeeding
xSevere kidney or liver dysfunction
Not FDA approved
Intermedin (Adrenomedullin-2) is an endogenous peptide hormone with systemic vascular and renal effects that warrant cautious use. As a vasodilator acting through CGRP and other peptide receptors, it can significantly lower blood pressure—a key safety consideration for hypotensive or cardiovascular-compromised individuals. Preclinical studies show dose-dependent hypotensive effects and tachycardia, limiting clinical translation. The compound remains largely experimental with limited safety data in humans outside specific research contexts.
xPregnancy and breastfeeding - insufficient safety data
xActive cardiovascular events (heart attack, stroke)
xSevere renal (kidney) impairment
xHypersensitivity to calcitonin family peptides
xUncontrolled endocrine disorders
Decision Guide
Which isright for you?
Choose Adrenomedullin if...
Cardiovascular health optimization
Maintaining healthy blood pressure
Recovery from illness or sepsis
Tissue protection and oxygen delivery
Choose Intermedin (Adrenomedullin-2) if...
Supporting cardiovascular health and heart function
Managing inflammation and oxidative stress
Improving overall vascular health and circulation